Title:
A novel pyrazine derivative as a CB2 receptor agonist
Document Type and Number:
Japanese Patent JP6322646
Kind Code:
B2
Abstract:
The invention relates to a compound of formula (I) wherein R1 to R4 are defined as in the description and in the claims. The compound of formula (I) is a CB2 receptor agonist for use in the treatment of several disorders, such as pain, atherosclerosis and glaucoma.
Inventors:
Durwasul, Baledi
Greetter, uwe
Nettecofen, Matthias
Laver, Stephan
Rogers-Evans, Mark
Schultz-Ghersh, Tanya
Greetter, uwe
Nettecofen, Matthias
Laver, Stephan
Rogers-Evans, Mark
Schultz-Ghersh, Tanya
Application Number:
JP2015545985A
Publication Date:
May 09, 2018
Filing Date:
December 04, 2013
Export Citation:
Assignee:
F. HOFFMANN-LA ROCHE AKTIENGESELLSCHAFT
International Classes:
C07D403/04; A61K31/497; A61K31/5377; A61K31/5386; A61K31/541; A61P1/02; A61P1/16; A61P3/10; A61P9/04; A61P9/10; A61P11/00; A61P13/12; A61P17/02; A61P19/00; A61P21/02; A61P25/04; A61P25/28; A61P27/02; A61P27/06; A61P29/00; A61P35/00; A61P37/06; C07D403/06; C07D403/14; C07D413/14; C07D417/14; C07D491/08; C07D491/107
Domestic Patent References:
| JP2010505788A |
Attorney, Agent or Firm:
Patent business corporation Tsukuni